Clinical trial NCT06404827: The Effect of Hippotherapy Simulator in Children with Spastic Cerebral Palsy
Official title: Investıgatıon of the Effect of Hıppotherapy Sımulator on Lower Extremıty Selectıve Motor Control, Balance and Trunk Control in Chıldren Wıth Spastıc Cerebral Palsy
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Cerebral Palsy
Keywords: Cerebral Palsy
Horseback riding simulator
Selective motor control
Balance
Lead sponsor: Hasan Kalyoncu University
Sponsor class: OTHER
First posted: 2024-05-08
Enrollment: 26
Sex: ALL
Minimum age (years): 5
Maximum age (years): 17
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The horseback riding simulator (HRS) is a dynamic robotic device that mimics the movement of a horse for hippotherapy purposes. HRS aims to improve the patient's balance, adaptation and provide postural adjustment by mimicking the rhythmic movements of the horse.

This study aims to research the potential benefits of the horseback riding simulator on the lower extremity selective motor control, balance and trunk control in children with Cerebral palsy.

Detailed description: Between the dates of the study, children with Cerebral palsy (CP) who meet the inclusion criteria will be allocated into two groups (intervention group, control group) by randomiZation method.

Intervention group: horseback riding simulator (HRS) will be applied in addition to routine Physiotherapy and Rehabilitation. This group will receive 20 minutes of routine physiotherapy training and 20 minutes of HRS application in addition to 2 sessions per week for 8 weeks.

Control group: Routine physiotherapy training will be applied within a specific programme for 40 minutes in 2 sessions per week for 8 weeks.

All the assessments will be performed before and after the training in the 8-week groups.

Eligibility criteria: Inclusion Criteria:

* Diagnosis of Spastic Cerebral Palsy
* Voluntary participation
* Age between 5-17 years,
* GMFCS Level I-II-III
* MACS Level I-II-III
* Modified Asworth Scale (MAS) Level 1-2-3
* Have the ability to sit with support

Exclusion Criteria:

* Having severe visual and hearing problems
* Severe distractibility problems and inability to follow task instructions,
* Not voluntary to participate in the research,
* Individuals with CP who have had hip or spine surgery in the last 6 months
* Individuals with CP who have undergone Botox in the last 6 months

Primary outcomes:
measure: Gross Motor Function Classification System (GMFCS)
timeFrame: At Baseline
measure: Manuel ability classification system (MACS)
timeFrame: At Baseline
measure: Change from Baseline Selective Control Assessment of the Lower Extremity at 8 weeks
timeFrame: Change from Baseline at 8 weeks
measure: Change from Baseline Pediatric balance scale at 8 weeks
timeFrame: Change from Baseline at 8 weeks
measure: Change from Baseline Trunk Control Measurement Scale at 8 weeks
timeFrame: Change from Baseline at 8 weeks
measure: Change from Baseline Modified Ashworth Scale (MAS) at 8 weeks
timeFrame: Change from Baseline at 8 weeks
Secondary outcomes:
Other outcomes:
Locations:
city: Gaziantep
country: Turkey
facility: Gaziantep
Study officials:
affiliation: Hasan Kalyoncu University
name: Yalçın Karabulut
role: PRINCIPAL_INVESTIGATOR
References: